BridgeMD
New treatment option for Ischemic Heart Disease
Official title Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients
ClinicalTrials.gov ID: NCT06377449
What this study is testing
- What it's testing
- The goal of this interventional is to assess advantages of the ultrasound examination of the lungs in the early postoperative period in cardiac surgical patients after heart surgeries requiring cardiopulmonary bypass. Evaluation of pulmonary complications and outcomes during mid-term follow-up, as well as comparison of ultrasound examination and traditional roentgenologic methods (X-ray examination and CT of the chest) will be performed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 and 15 December 2024
- signed informed consent for participation in the study
You likely can't join if
- reoperations on the open heart with CPB
- surgical procedures on lungs and lung cancer in the anamnesis
- chronic obstructive pulmonary disease, stage III
- chronic kidney disease, stages 4 and 5
- patients with low Risk Score profile by the Society of Thoracic Surgeons
The study team makes the final eligibility decision.
Where it's taking place
- Saint Petersburg, Sankt-Peterburg, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint Petersburg, Sankt-Peterburg, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.